Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma

Cancer Science

Volumn 99, Issue 3, 2008, Pages 518-523

  Dohi, Osamu ^a,b   Hatori, Masahito ^b   Suzuki, Takashi ^b   Ono, Katsuhiko ^b   Hosaka, Masami ^b   Akahira, Jun Ichi ^b   Miki, Yasuhiro ^b   Nagasaki, Shuji ^b   Itoi, Eiji ^b   Sasano, Hironobu ^b  

^a TOHOKU ROSAI HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HYDROXYFLUTAMIDE; KI 67 ANTIGEN; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE; STEROID RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; METABOLIC REGULATION; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STEROID BLOOD LEVEL;

EID: 38949165061     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00673.x     Document Type: Article

References (38)

1. Hochner-Celnikier D, Manor O, Garbi B, Chajek-Shaul T. Gender gap in cerebrovascular accidents: Comparison of the extent, severity, and risk factors in men and women aged 45-65. Int J Fertil Womens Med 2005; 50: 122-8.
2. Kojima S, Murakami K, Kimura G et al. A gender difference in the association between salt sensitivity and family history of hypertension. Am J Hypertens 1992; 5: 1-7.
3. Moriguchi Y, Maeda M, Igarashi T et al. Age and gender effect on alexithymia in large, Japanese community and clinical samples: A cross-validation study of the Toronto Alexithymia Scale (TAS-20). Biopsychosoc Med 2007; 1: 7.
4. O'Connor MI. Osteoarthritis of the hip and knee: Sex and gender differences. Orthop Clin North Am 2006; 37: 559-68.
5. Ragonese P, D'Amelio M, Savettieri G. Implications for estrogens in Parkinson's disease: An epidemiological approach. Ann New York Acad Sci 2006; 1089: 373-82.
6. Reyes D, Lew SQ, Kimmel PL. Gender differences in hypertension and kidney disease. Med Clin North Am 2005; 89: 613-30.
7. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thrombosis Haemostasis 2006; 96: 267-73.
8. Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gender Med 2004; 1: 12-17.
9. Boden SD, Joyce ME, Oliver B, Heydemann A, Bolander ME. Estrogen receptor mRNA expression in callus during fracture healing in the rat. Calcified Tissue Int 1989; 45: 324-5.
10. Colvard DS, Eriksen EF, Keeting PE et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989; 86: 854-7.
11. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996; 11: 337-49.
12. Kalifa C, Laurence B, Le Deley M-C. Neoadjuvant treatment in osteosarcomas. Bull Cancer 2006; 93: 1115-20.
13. Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997; 33: 1725-31.
14. Lewis VO, Raymond K, Mirza AN, Lin P, Yasko AW. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response. Clin Orthop Related Res 2006; 450: 60-6.
15. Mori K, Redini F, Gouin F, Cherrier B, Heymann D. Osteosarcoma: Current status of immunotherapy and future trends (Review). Oncol Reports 2006; 15: 693-700.
16. Quan GM, Choong PF. Anti-angiogenic therapy for osteosarcoma. Cancer Metastasis Rev 2006; 25: 707-13.
17. Unni KK, Inwards CY, Bridge JA, Kindglom LG, Wold LE. Tumors of the Bones and Joints. Washington, DC: American Registry of Pathology, 2005.
18. Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci 2005; 83: 136-48.
19. Walker MJ, Chaudhuri PK, Beattie CW, Das Gupta TK. Steroid receptors in malignant skeletal tumors. Cancer 1980; 45: 3004-7.
20. Noguchi T, Kitawaki J, Tamura T et al. Relationship between aromatase activity and steroid receptor levels in ovarian tumors from postmenopausal women. J Steroid Biochem Mol Biol 1993; 44: 657-60.
21. Fazleabas AT, Brudney A, Chai D, Langoi D, Bulun SE. Steroid receptor and aromatase expression in baboon endometriotic lesions. Fertil Steril 2003; 80 (Suppl.2): 820-7.
22. Balthazart J, Baillien M, Charlier TD, Cornil CA, Ball GF. Multiple mechanisms control brain aromatase activity at the genomic and non-genomic level. J Steroid Biochem Mol Biol 2003; 86: 367-79.
23. Dowsett M, Martin LA, Smith I, Johnston S. Mechanisms of resistance to aromatase inhibitors. J Steroid Biochem Mol Biol 2005; 95: 167-72.
24. Dowsett M, Folkerd E, Doody D, Haynes B. The biology of steroid hormones and endocrine treatment of breast cancer. Breast 2005; 14: 452-7.
25. Sasano H, Anderson TJ, Silverberg SG et al. The validation of new aromatase monoclonal antibodies for immunohistochemistry - a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol 2005; 95: 35-9.
26. Ishizuka M, Hatori M, Suzuki T et al. Sex steroid receptors in rheumatoid arthritis. Clin Sci 2004; 106: 293-300.
27. McCarty Jr KS, Miller LS, Cox EB, Konrath J, McCarty Sr KS. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985; 109: 716-21.
28. Suzuki T, Miki Y, Moriya T et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res 2004; 64: 4670-6.
29. Isobe I, Michikawa M, Yanagisawa K. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid betaprotein and chloroquine in cultured rat astrocytes. Neurosci Lett 1999; 266: 129-32.
30. Ikegami A, Inoue S, Hosoi T et al. Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells. Endocrinol 1994; 135: 782-9.
31. MacNamara P, O'Shaughnessy C, Manduca P, Loughrey HC. Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures. Calcif Tissue Int 1995; 57: 436-41.
32. Liang M, Liao EY, Xu X, Luo XH, Xiao XH. Effects of progesterone and 18-methyl levonorgestrel on osteoblastic cells. Endocr Res 2003; 29: 483-501.
33. MacNamara P, Loughrey HC. Progesterone receptor A and B isoform expression in human osteoblasts. Calcified Tissue Int 1998; 63: 39-46.
34. Luo XH, Liao EY. Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells. Endocr Res 2003; 29: 343-51.
35. Chen FP, Hsu T, Hu CH, Wang WD, Wang KC, Teng LF. Expression of estrogen receptors alpha and beta in human osteoblasts: Identification of exon-2 deletion variant of estrogen receptor beta in postmenopausal women. Chang Gung Med J 2004; 27: 107-15.
36. Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S, Spelsberg TC. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol Endocrinol 2005; 19: 1555-68.
37. Solakidi S, Psarra AM, Sekeris CE. Differential subcellular distribution of estrogen receptor isoforms. localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. Biochim Biophys Acta 2005; 1745: 382-92.
38. Zhuang YH, Blauer M, Pekki A, Tuohimaa P. Subcellular location of androgen receptor in rat prostate, seminal vesicle and human osteosarcoma MG-63 cells. J Steroid Biochem Mol Biol 1992; 41: 693-6.